Home > Compound List > Product Information
Geranylgeranylacetone_Molecular_structure_CAS_6809-52-5)
Click picture or here to close

Geranylgeranylacetone

Catalog No. G5048 Name Sigma Aldrich
CAS Number 6809-52-5 Website http://www.sigmaaldrich.com
M. F. C23H38O Telephone 1-800-521-8956
M. W. 330.54722 Fax
Purity ≥98% (HPLC) Email
Storage protect from light Chembase ID: 154595

SYNONYMS

IUPAC name
6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
IUPAC Traditional name
6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
Synonyms
Teprenone
GGA
UNII-S8S8451A4O
Selbex
6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one, mixture of (5E,9E,13E) and (5Z,9E,13E) isomers

DATABASE IDS

MDL Number MFCD00869547
CAS Number 6809-52-5

PROPERTIES

Empirical Formula (Hill Notation) C23H38O
Purity ≥98% (HPLC)
Apperance clear liquid
Solubility DMSO: >5 mg/mL
MSDS Link Download
RTECS RA5391300
Storage Condition protect from light
Storage Temperature -20°C
German water hazard class 3

DETAILS

Description (English)
Biochem/physiol Actions
Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.
Description (简体中文)
Biochem/physiol Actions
Geranylgeranylacetone can induce expression of HSP70, HSPB8, and HSPB1. Induction of HSP70 expression is protective against the development of various diseases, such as inflammatory bowel disease, hypoxic/ischemic brain injury and spinal and bulbar muscular atrophy (cytoprotective and anti-inflammatory effects). Reports indicate that GGA protects against NSAID-induced gastric and intestinal lesions by induction of HSP70 expression. Other studies have shown that GGA induces expression of HSPB8 and HSPB1 and reduces the formation of amyloid oligomers as well as insoluble aggregates in HSPB5 R120G TG mice.

REFERENCES